Masaaki Eiro, Tetsuo Katoh, Tsuyoshi Watanabe. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » 2-PyridinylmethylsulfinylbenzimidazolesAdultAlkalosis/drug therapyAlkalosis/etiologyAnorexia Nervosa/bloodAnorexia Nervosa/complicationsAnorexia Nervosa/drug therapyBicarbonates/metabolismBulimia/complicationsChlorides/bloodFemaleHumansHypokalemia/drug therapyHypokalemia/etiologyLansoprazoleOmeprazole/analogs & derivativesOmeprazole/therapeutic useProton Pump Inhibitors
Substances： See more » 2-PyridinylmethylsulfinylbenzimidazolesBicarbonatesChloridesProton Pump InhibitorsLansoprazoleOmeprazole
Year: 2002 PMID： 11784888 DOI： 10.1056/NEJM200201103460218
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245